Globus Medical Inc (NYSE: GMED) on Tuesday, plunged -0.76% from the previous trading day, before settling in for the closing price of $72.14. Within the past 52 weeks, GMED’s price has moved between $49.33 and $94.93.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 28.52%. The company achieved an average annual earnings per share of 9.79%. With a float of $113.96 million, this company’s outstanding shares have now reached $114.99 million.
Let’s determine the extent of company efficiency that accounts for 5300 employees. In terms of profitability, gross margin is 55.35%, operating margin of 8.52%, and the pretax margin is 4.79%.
Globus Medical Inc (GMED) Breakdown of a Key Holders of the stock
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Globus Medical Inc is 17.14%, while institutional ownership is 80.07%. The most recent insider transaction that took place on Feb 28 ’25, was worth 590,100. In this transaction Director of this company sold 7,500 shares at a rate of $78.68, taking the stock ownership to the 35,384 shares. Before that another transaction happened on Feb 28 ’25, when Company’s Director proposed sale 7,500 for $78.67, making the entire transaction worth $590,000.
Globus Medical Inc (GMED) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.86 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 9.79% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.64% during the next five years compared to -13.26% drop over the previous five years of trading.
Globus Medical Inc (NYSE: GMED) Trading Performance Indicators
Globus Medical Inc (GMED) is currently performing well based on its current performance indicators. A quick ratio of 1.77 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.55. Likewise, its price to free cash flow for the trailing twelve months is 28.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.74, a number that is poised to hit 0.75 in the next quarter and is forecasted to reach 3.96 in one year’s time.
Technical Analysis of Globus Medical Inc (GMED)
Looking closely at Globus Medical Inc (NYSE: GMED), its last 5-days average volume was 1.55 million, which is a jump from its year-to-date volume of 1.33 million. As of the previous 9 days, the stock’s Stochastic %D was 27.01%. Additionally, its Average True Range was 2.29.
During the past 100 days, Globus Medical Inc’s (GMED) raw stochastic average was set at 10.40%, which indicates a significant decrease from 21.94% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 29.71% in the past 14 days, which was higher than the 27.22% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $84.17, while its 200-day Moving Average is $76.29. However, in the short run, Globus Medical Inc’s stock first resistance to watch stands at $72.26. Second resistance stands at $72.92. The third major resistance level sits at $73.57. If the price goes on to break the first support level at $70.95, it is likely to go to the next support level at $70.30. Now, if the price goes above the second support level, the third support stands at $69.64.
Globus Medical Inc (NYSE: GMED) Key Stats
Market capitalization of the company is 11.45 billion based on 137,542K outstanding shares. Right now, sales total 2,519 M and income totals 102,980 K. The company made 657,290 K in profit during its latest quarter, and 26,510 K in sales during its previous quarter.
